Literature DB >> 17252557

Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats.

Peter Hammarsten1, Stina Häggström Rudolfsson, Roger Henriksson, Pernilla Wikström, Anders Bergh.   

Abstract

BACKGROUND: The epidermal growth factor receptor (EGFR) mediates regulatory signals in the normal prostate, but the functional importance of this is unclear.
METHODS: Adult male rats were castrated, or castrated + treated with gefitinib (Iressa, ZD1839), an EGFR tyrosine kinase inhibitor, for 3 days. Seven-day castrated rats were treated with testosterone, or testosterone + gefitinib, for 3 days.
RESULTS: Both castration alone and testosterone treatment in castrated animals increased the mRNA and protein levels of EGFR and phospho-EGFR in the ventral prostate. Inhibition of EGFR during castration and during testosterone-stimulated prostate growth resulted in a decrease in total epithelial weight, epithelial cell proliferation, endothelial cell proliferation, and increased epithelial cell apoptosis.
CONCLUSIONS: This study suggests that increased EGFR signaling during castration mediates stimulatory effects balancing castration-induced prostate regression, and that EGFR signaling is a necessary component in testosterone-stimulated prostate growth. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17252557     DOI: 10.1002/pros.20529

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

Review 1.  Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.

Authors:  A M Traish; A Morgentaler
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

Review 2.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 3.  [Role of androgen receptors in hormone-refractory prostate cancer: molecular basics and experimental therapy approaches].

Authors:  L Rinnab; A Hessenauer; S V Schütz; E Schmid; R Küfer; F Finter; R E Hautmann; K D Spindler; M V Cronauer
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

4.  mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.

Authors:  Federica Finetti; Erika Terzuoli; Antonio Giachetti; Raffaella Santi; Donata Villari; Hiromi Hanaka; Olof Radmark; Marina Ziche; Sandra Donnini
Journal:  Endocr Relat Cancer       Date:  2015-06-25       Impact factor: 5.678

5.  Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.

Authors:  Geetanjali Kharmate; Elham Hosseini-Beheshti; Josselin Caradec; Mei Yieng Chin; Emma S Tomlinson Guns
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

6.  Mesenchymal stem cells- derived exosomes inhibit the expression of Aquaporin-5 and EGFR in HCT-116 human colorectal carcinoma cell line.

Authors:  Amir Hossein Mansourabadi; Azin Aghamajidi; Fatemeh Faraji; Shirin Taghizadeh; Leila Mohamed Khosroshahi; Mona Bahramkiya; Maryam Azimi
Journal:  BMC Mol Cell Biol       Date:  2022-09-16

7.  Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.

Authors:  Peter Hammarsten; Mariateresa Cipriano; Andreas Josefsson; Pär Stattin; Lars Egevad; Torvald Granfors; Christopher J Fowler
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

8.  ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.

Authors:  Peter Hammarsten; Johanna Winther; Stina H Rudolfsson; Jenny Häggström; Amar Karalija; Lars Egevad; Torvald Granfors; Christopher J Fowler
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

9.  Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.

Authors:  Marie Lundholm; Christina Hägglöf; Maria L Wikberg; Pär Stattin; Lars Egevad; Anders Bergh; Pernilla Wikström; Richard Palmqvist; Sofia Edin
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.